Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways

Although trisomy 12 (+12) chronic lymphocytic leukemia (CLL) comprises about 20% of cases, relatively little is known about its pathophysiology. These cases often demonstrate atypical morphological and immunophenotypic features, high proliferative rates, unmutated immunoglobulin heavy chain variable...

Descripción completa

Detalles Bibliográficos
Autores principales: Abruzzo, Lynne V., Herling, Carmen D., Calin, George A., Oakes, Christopher, Barron, Lynn L., Banks, Haley E., Katju, Vikram, Keating, Michael J., Coombes, Kevin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269288/
https://www.ncbi.nlm.nih.gov/pubmed/29976738
http://dx.doi.org/10.3324/haematol.2018.190132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269288/
https://www.ncbi.nlm.nih.gov/pubmed/29976738
http://dx.doi.org/10.3324/haematol.2018.190132

Ejemplares similares